Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Ozoaqua scar care after open abdominal surgery compared with standard care

Official title: Prospective, Randomized, Evaluator-blinded Clinical Study to Compare a Post-surgical Scar Care Protocol Using OzoAqua Products Versus Standard Care in Open Abdominal Surgery.

Run by Laboratorios Ozoaqua · NCT07678372 · Data updated 2026-11-12

This study tests if adding Ozoaqua products after open abdominal surgery improves the scar quality at 3 months compared with usual care.

More Wound Healing trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment144 (estimated)
SponsorLaboratorios Ozoaqua
Industry-sponsored
Locations2 sites (Pamplona, Navarre and 1 other locations)
StatusRecruiting
StartedAugust 14, 2026
Main results expectedJuly 6, 2027
Study endsJuly 6, 2027
Registry record updatedOctober 30, 2026
Trial IDNCT07678372 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults undergoing scheduled open abdominal surgery with primary wound closure and an assessable linear abdominal scar.

Probably not a fit

Patients who do not respond to topical scar care or who have factors that predispose to poor wound healing despite intervention may not see a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized study compares a postoperative scar care protocol using ozonated Ozoaqua products to standard care in adults undergoing open abdominal surgery. A blinded evaluator will assess scar quality at 3 months, while treatment is open-label due to the topical nature of the intervention. The study is single-center, with 1:1 randomization to either standard care plus Ozoaqua or standard care alone, and includes preoperative consent, daily in-hospital wound assessments, and follow-up visits at 2 weeks and 1 month. Primary outcome is scar quality at 3 months, with safety and adherence monitored throughout the perioperative period.

Why it matters

Potential benefit: If successful, patients could experience improved scar appearance and healing with a simple topical regimen after open abdominal surgery.

How similar studies have gone: Other wound-care studies using topical agents show variable scar outcomes; this trial investigates a specific ozonated protocol in a similar surgical context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Scheduled open abdominal surgery
* Primary wound closure
* Assessable linear abdominal scar
* Signed informed consent
* Ability to complete 3-month follow-up

Exclusion Criteria:

* Known allergy to treatment components
* Active infection or significant dehiscence in the immediate postoperative period
* Planned use of specific scar treatments -silicone products, laser therapy, local corticosteroids- except as clinical rescue treatment
* Inability to complete follow-up
* Participation in another study that may interfere with wound healing

Where it's running

  • Clínica Universidad de Navarra
    Pamplona, Navarre, Spain
    Recruiting
  • Clínica Universidad de Navarra, sede Madrid
    Madrid, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.